New cancer drug set to begin trials

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |May 31, 2016
    PubMed

    Insights

    Clinical trials for a new cancer drug are set to begin in Manchester. This innovative treatment aims to stop the spread of cancer, offering new hope for patients.

    Area of Science:

    • Oncology
    • Clinical Pharmacology

    Background:

    • Cancer metastasis remains a significant challenge in treatment.
    • Developing therapies to inhibit cancer cell spread is a critical unmet need.

    Purpose of the Study:

    • To initiate the first clinical trials of a novel drug designed to halt cancer metastasis.
    • To evaluate the safety and efficacy of this investigational anti-metastatic agent.

    Main Methods:

    • Phase I/II clinical trial design.
    • Recruitment of patients with specific cancer types.
    • Administration of the investigational drug and monitoring of outcomes.

    Main Results:

    • Anticipated initiation of clinical trials in Manchester.
    • Potential for the drug to halt cancer progression.

    Conclusions:

    • The commencement of these trials marks a significant step forward in cancer research.
    • This drug holds promise for a new therapeutic strategy against metastatic cancer.

    Related Concept Videos

    Clinical Trials: Overview01:11

    Clinical Trials: Overview

    Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
    5.4K
    Clinical Trials01:16

    Clinical Trials

    Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
    There are four phases in a clinical trial. A phase one...
    11.1K
    Cancer Therapies02:49

    Cancer Therapies

    3.0K
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    10.6K
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    1.5K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.1K